SECURITY AGREEMENTSecurity Agreement • April 27th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • New York
Contract Type FiledApril 27th, 2005 Company Industry JurisdictionTHIS SECURITY AGREEMENT (this “Agreement”) is made as of April 21, 2005, by and among GENAISSANCE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and the Investors set forth on the signatures page affixed hereto (each an “Investor” and collectively, the “Investors”).
SECURITY AGREEMENTSecurity Agreement • April 27th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • New York
Contract Type FiledApril 27th, 2005 Company Industry JurisdictionTHIS SECURITY AGREEMENT (this “Agreement”) is made as of April 21, 2005, by and among LARK TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and the Investors set forth on the signatures page affixed hereto (each an “Investor” and collectively, the “Investors”).